Brandywine Global Investment Management, LLC

Q3 2022 13F-HR Detailed Holdings

Location
Philadelphia, PA
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
731
Total value ($000)
$10,732,541
Net value change ($000)
-760,661 (-6.6%)
New positions
67
Sold out positions
55
Turnover %
8.2%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 8/11/2022 Next filing: 2/10/2023 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
T 55,226 160.7%
COP 53,244 137.7%
Horizon Therapeutics Public Ltd Co 41,709 NEW
CAT 41,690 422.4%
MS 40,018 67.2%
GSK 37,048 NEW
ZBRA 32,353 NEW
CSCO 30,693 24.5%
HLN 28,611 NEW
PIONEER NATURAL RESOURCES CO 28,547 NEW
Top Reduces (Value $000, Stocks/ETFs)
SO -57,710 -94.1%
NI -57,646 -95.0%
GSK -57,005 -100.0%
GD -56,568 -100.0%
JNJ -55,244 -53.4%
NOC -53,165 -100.0%
PFE -49,337 -21.0%
JNP -43,693 -93.9%
CI -43,660 -40.0%
THO -43,246 -80.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None